Reversible Symptomatic Myocarditis Induced by All-Trans Retinoic Acid Administration during Induction Treatment of Acute Promyelocytic Leukemia: Rare Cardiac Manifestation as a Retinoic Acid Syndrome

Treatment by All-trans retinoic acid (ATRA) followed by anthracycline-AraC chemotherapy has improved the outcome of acute promyelocytic leukemia. ATRA is usually well tolerated, but a few major side effects can be observed. Retinoic acid syndrome (RAS) often occurs during the induction chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seonghoon, Kim, Hyeong-Su, Jung, Chang-Soo, Jung, Seong-Woong, Lee, Yun-Ja, Rheu, Jin-Kyeong, Jo, Jung-Rae, Lee, Nam-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Echocardiography 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150704/
https://www.ncbi.nlm.nih.gov/pubmed/21860725
http://dx.doi.org/10.4250/jcu.2011.19.2.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150704/
https://www.ncbi.nlm.nih.gov/pubmed/21860725
http://dx.doi.org/10.4250/jcu.2011.19.2.95

Ejemplares similares